Literature DB >> 404433

Early experience in using and 18 Me V linear accelerator for mycosis fungoides at Howard University Hospital.

P P Kumar, K Henschke, K P Mandal, J R Nibhanupudy, I S Patel.   

Abstract

This paper describes the problems and solutions in using 18 MeV linear accelerator, with minimum 6 MeV electron capability, for total skin irradiation for mycosis fungoides. The 6 MeV electron energy can be degraded to acceptable electron energy of 3.2 MeV by interposing a plexiglass sheet of 9.6 mm in the beam. To minimize the bremsstrahlung, the degrading plexiglass should be kept away from the machine head. A wide area with uniform dose distribution over single plane can be achieved by using dual fields but homogenous dose distribution over irregular body surface cannot be achieved mainly because of self-shielding. The nails and the ocular lens can be easily shielded from the low energy electrons with 1.5 mm lead shield.

Entities:  

Mesh:

Year:  1977        PMID: 404433      PMCID: PMC2538398     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  11 in total

1.  X-RAY CONTAMINATION IN TOTAL-SKIN ELECTRON THERAPY OF LYMPHOMA CUTIS AND EXFOLIATIVE DERMATITIS.

Authors:  J H GROLLMAN; S M BIERMAN; J E MORGAN; R E OTTOMAN
Journal:  Radiology       Date:  1965-08       Impact factor: 11.105

2.  Ten year experience with low megavolt ellectron therapy.

Authors:  M I SMEDAL; D O JOHNSTON; F A SALZMAN; J G TRUMP; K A WRIGHT
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1962-08

3.  10 mev. betatron electron beam therapy adapted to a case of mycosis fungoides.

Authors:  T KITAGAWA
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1962-08

4.  High energy electrons for the treatment of extensive superficial malignant lesions.

Authors:  J G TRUMP; K A WRIGHT; W W EVANS; J H ANSON; H F HARE; J L FROMER; G JACQUE; K W HORNE
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1953-04

5.  Total-skin electron-beam therapy of lymphoma cutis and generalized psoriasis: clinical experiences and adverse reactions.

Authors:  J H Grollman; A M Bierman; R E Ottoman; J E Morgan; J Horns
Journal:  Radiology       Date:  1966-11       Impact factor: 11.105

6.  Mycosis fungoides with extracutaneous dissemination: a distinct clinicopathologic entity.

Authors:  J C Long; M C Mihm
Journal:  Cancer       Date:  1974-11       Impact factor: 6.860

7.  Dosimetry for total-body electron-beam therapy in the treatment of mycosis fungoides.

Authors:  G R Edelstein; T Clark; J G Holt
Journal:  Radiology       Date:  1973-09       Impact factor: 11.105

8.  Mycosis fungoides: pathologic findings in staging laparotomies.

Authors:  D Variakojis; A Rosas-Uribe; H Rappaport
Journal:  Cancer       Date:  1974-06       Impact factor: 6.860

9.  Total-skin electron treatment of mycosis fungoides.

Authors:  Z Fuks; M A Bagshaw
Journal:  Radiology       Date:  1971-07       Impact factor: 11.105

10.  Patient dosimetry in the electron treatment of large superficial lesions.

Authors:  V Page; A Gardner; C J Karzmark
Journal:  Radiology       Date:  1970-03       Impact factor: 11.105

View more
  4 in total

1.  Rotational subtotal skin electron beam therapy for management of carcinoma en cuirasse.

Authors:  P P Kumar; R R Good; E O Jones
Journal:  J Natl Med Assoc       Date:  1987-07       Impact factor: 1.798

2.  Rotation technique for superficial total body electron beam irradiation.

Authors:  P P Kumar; I S Patel
Journal:  J Natl Med Assoc       Date:  1978-07       Impact factor: 1.798

3.  Problems and solutions in achieving uniform dose distribution in superficial total body electron therapy.

Authors:  P P Kumar; U K Henschke; J R Nibhanupudy
Journal:  J Natl Med Assoc       Date:  1977-09       Impact factor: 1.798

4.  Time-gated scintillator imaging for real-time optical surface dosimetry in total skin electron therapy.

Authors:  Petr Bruza; Sarah L Gollub; Jacqueline M Andreozzi; Irwin I Tendler; Benjamin B Williams; Lesley A Jarvis; David J Gladstone; Brian W Pogue
Journal:  Phys Med Biol       Date:  2018-05-02       Impact factor: 3.609

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.